Neurocrine Biosciences, Inc. (MM) Stock Price - NBIX

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
ULTIMATE TRADER
Monthly Subscription
for only
$65.99
Big Cap Pro
Monthly Subscription
for only
$40.31
VAT not included
After Hours
Last Trade
Last: $ 41.50 ▲ 0.23 (0.56%)
Company Name Stock Ticker Symbol Market Type ISIN
Neurocrine Biosciences, Inc. (MM) NBIX NASDAQ Common Stock US64125C1099
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.35 -0.84% 41.27 41.889 40.80 41.60 41.62 20:00:00
Bid Price Ask Price Spread Spread % News
37.80 44.04 6.24 14.17% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,911 768,940 $ 41.1975 $ 31.68M 1.01M 31.25 - 55.15
Last Trade Time Type Quantity Stock Price Currency
18:26:03 formt 200 $41.50 USD

Neurocrine Biosciences, Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.59B 86.87M $ -88.93M -1.05 - 62.9M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.71M $ 0.00 0.00% -15.9k 99.70%

more financials information »

Neurocrine Biosciences, Inc. (MM) News

Date Time Source News Article
1/18/201718:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/18/201718:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/18/201718:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/18/201718:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/18/201718:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/18/201718:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/17/201716:01PR Newswire (US)Neurocrine Announces Completion of Phase II Clinical Study..

Historical NBIX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week41.1743.5738.8441.64051M3M2M0.100.24%
1 Month39.1345.8937.34541.4233648k3M1M2.145.47%
3 Months44.4954.9137.34543.9144326k3M1M-3.22-7.24%
6 Months49.1355.1537.34546.2289307k3M856k-7.86-16.00%
1 Year50.8555.1531.2544.0626307k3M933k-9.58-18.84%
3 Years19.0058.4612.1736.758409M866k22.27117.21%
5 Years8.4258.466.2528.3926019M772k32.85390.14%

Neurocrine Biosciences, Inc. (MM) Description

Neurocrine Biosciences, Inc., discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170122 06:01:06